University of Alabama at Birmingham,IDS Pharmacy is a clinical research site located in Birmingham, Alabama, United States 35249.
Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Alabama at Birmingham,IDS Pharmacy has participated in 8 clinical trials with 3 currently active.
Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Birmingham
Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Alabama at Birmingham,IDS Pharmacy has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Alabama at Birmingham,IDS Pharmacy has 8 clinical trials on record, with 3 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma.
University of Alabama at Birmingham,IDS Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.